中华心血管病杂志
中華心血管病雜誌
중화심혈관병잡지
Chinese Journal of Cardiology
2014年
6期
455-457
,共3页
Sung-A Chang%李静惠
Sung-A Chang%李靜惠
Sung-A Chang%리정혜
Clinical guideline for treatment of pulmonary arterial hypertension (PAH) has been changing during the past 10 years with development of targeted therapy for PAH.Treatment of PAH should include general measures and supportive care,treatment of associated disease,targeted treatment for PAH,and lung transplantation in advanced cases.Targeted therapy for PAH can improve symptom,quality of life and time to clinical worsening in PAH patients.Regular follow-up to evaluate the treatment efficacy is essential and insufficient treatment efficacy should be modified with other class of medication or preparing lung transplantations.Research for new medication is actively performed and novel drug is expected to be improving survival of PAH patients.
